Brimonidine Tartrate

Brimonidine is an alpha-2 adrenergic agonist used for treating glaucoma and hypertension, along with facial erythema in rosacea.

Technical Specifications:

• CAS Number: 79570-19-7
• Assay: 99.0%min
• Molecular Formula: C11H10BrN5.C4H6O6
• Molecular Weight: 442.22
• Appearance: White to slightly yellowish powder 
• Solubility: Soluble in water, slightly soluble in methanol
• Identification: HNMR,HPLC
• PH: 3.0~4.5
• Melting point: 205°C~210°C

How does it work?

Following ocular administration, brimonidine tartrate constricts the blood vessels, decreasing aqueous humor production. The outflow of aqueous humor is also enhanced by Brimonidine tartrate. Glaucoma patients take this drug to reduce intraocular pressure.

Applications Or where it is used:

Open-angle glaucoma or high fluid pressure in the eye is treated with this medication. When the fluid pressure in the eye is lowered, the risk of vision loss, nerve damage, or blindness is greatly reduced.

How to use:

Three times a day, approximately eight hours apart, one drop of brimonidine tartrate is recommended in the affected eye. In order to lower intraocular pressure, this medication is sometimes taken in combination with other topical ophthalmic drugs. It is recommended that if more than one topical ophthalmic product is to be used, the product should be instilled at least 5 minutes apart.

Side effects:

• Eye discomfort/itching/redness/burning/stinging
• Nausea
• Upset stomach
• Feeling like something is in your eye
• Blurred vision
• Redness of the eye or eyelid
• Swollen or puffy eyes
• Sensitivity to light

Warnings and precautions while using this medication:

The side effects of this medication are more apparent in children, especially drowsiness.